Phage-Derived Endolysin: A Novel Therapy for Acute Graft-Versus-Host Disease (VIDEO)

The Institute of Medical Science, The University of Tokyo

Caption

Identification of bacteriophage-derived enzyme and its antibacterial activity can contribute to novel therapies that target biofilm-forming bacteria and help in the treatment against acute graft-versus-host disease.

Credit

Kosuke Fujimoto, Seiya Imoto, and Satoshi Uematsu from The University of Tokyo

Usage Restrictions

Do not reuse without permission.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.